Avvaa World Health Care Products Inc (AVVH)

[originunknown]

AVVW avVaa World Health Care Products Reports Annual Results
PR Newswire - September 14, 2006 8:01 AM (EDT)

LUMBY, British Columbia, Sept 14, 2006 /PRNewswire-FirstCall via COMTEX/ -- avVaa World Health Care Products, Inc. (OTC Bulletin Board: AVVW), a biotech company offering global customers therapeutic skin and health care products, is pleased to announce it has filed its SEC form 10-KSB annual report containing financial and operating results for the year ended May 31, 2006.

avVaa reports a loss for the year ended May 31, 2006 of $4,035,067 or $(0.10) per share as compared to a loss of $2,949,420 for the comparable year ended May 31, 2005 or ($0.11) per share.

Jack Farley Chairman and CEO of AVVAA World Health Care Products said, "We have been encouraged by the results of recent marketing and sales initiatives worldwide. As we continue to rollout production, distribution and sales of our natural skin and health care products, management remains focused on growing market share for all of our product lines and in our sector overall."

This press release briefly summarizes only certain portions of the Company's Annual Report on Form 10-K SB for the year ended for May 31, 2006 and readers should review the entire report filed with the SEC; available at www.sec.gov.

About avVaa World Health Care Products

avVaa World Health Care Products (AVVW) is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers, and now even for pets and equine. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat symptoms of common skin ailments, including: eczema, psoriasis and acne.

avVaa is poised to manufacture and market its OTC Neuroskin line of skin care products through mass food and drug channels in the United States and globally.

For additional information on avVaa contact Jack Farley CEO / Chairman, at 1-866-772-8822 or visit: www.avvaa.com or www.otcfn.com/avvw

Investor Relations: Merle Goertz (West Coast) of avVaa World Health Care Products, 1-604-688-2349; or Rick McCaffrey of OTC Financial Network, 1-781-444-6100 ext. 625

Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward- looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of AVVAA World Health Care Products, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.

Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of AVVAA World Health Care Products, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.

SOURCE avVaa World Health Care Products

Jack Farley, CEO / Chairman, avVaa World Health Care Products, [phone];
Investor Relations, Merle Goertz, (West Coast), of avVaa World Health Care Products,
[phone]; or Rick McCaffrey of OTC Financial Network, 1-781-444-6100 ext. 625

http://www.prnewswire.com

Copyright (C) 2006 PR Newswire. All rights reserved.